Identificador persistente para citar o vincular este elemento: https://accedacris.ulpgc.es/handle/10553/139932
Título: Impact of a glutamine-enriched peptide formula on gastrointestinal toxicity and on the interruption of oncologic treatment in patients with adenocarcinoma of the rectum
Autores/as: Salas-Salas, Barbara Gabriela
Ferrera Alayón, Laura 
Calleja-Fernandez, Alicia
Chicas-Sett, Rodolfo
Nogues-Ramia, Eva
Zafra-Martin, Juan
Lloret Sáez-Bravo, Marta 
Clasificación UNESCO: 32 Ciencias médicas
320101 Oncología
3208 Farmacodinámica
Palabras clave: Induced Oral Mucositis
Elemental Diet
Radiation Enteritis
Colorectal-Cancer
Chemotherapy, et al.
Fecha de publicación: 2024
Publicación seriada: Frontiers In Nutrition 
Resumen: Background: Patients with rectal cancer may develop gastrointestinal toxicity associated with chemo-radiotherapeutic treatment that conditions their clinical, functional, and nutritional evolution. The aim of the study was to evaluate the efficacy of nutritional supplementation with a glutamine-enriched peptide diet (PD) compared to exclusive dietary advice (DA) on gastrointestinal toxicity, interruption of oncologic treatment, and nutritional evolution in patients with rectal cancer undergoing neoadjuvant treatment.Methods Prospective cohort study with two groups. Patients with rectal cancer in treatment with neoadjuvant chemo-radiotherapy were recruited. One group of patients received nutritional supplementation with PD, and another group received DA exclusively, from the beginning of radiotherapy until the time of surgery. Intestinal toxicity was evaluated with the CTCAE 5.0 scale, functionality with the ECOG scale and nutritional status with GLIM criteria.Results Fifty-four patients were initially selected, although 51 were finally enrolled: 25 in the PD group and 26 in the DA group. There was a reduction in the risk of diarrhea in the PD group midway through radiotherapy treatment [RR of 0.218 (95% CI = 0.052-0.923)] and at the end of treatment [RR of 0.103 (95% CI = 0.020-0.537)], as well as a reduction in the risk of developing mucositis at the end of treatment [RR of 0.405 (95% CI = 0.280-0.584)]. The use of a PD also decreased treatment interruptions with radiotherapy in stage III patients (0 vs. 15.8%, p = 0.049) and in malnourished patients (0 vs. 18.2%, p = 0.040).Conclusion The glutamine-enriched peptide diet had a protective effect on the development of diarrhea and mucositis associated with chemo-radiotherapeutic treatment in patients with colorectal cancer under neoadjuvant treatment, as well as the interruption of radiotherapeutic treatment.
URI: https://accedacris.ulpgc.es/handle/10553/139932
ISSN: 2296-861X
DOI: 10.3389/fnut.2024.1414367
Fuente: Frontiers In Nutrition [ISSN 2296-861X], v. 11, (Diciembre 2024)
Colección:Artículos
Adobe PDF (711,87 kB)
Vista completa

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.